000276106 001__ 276106
000276106 005__ 20240229154957.0
000276106 0247_ $$2doi$$a10.1038/s41418-023-01173-6
000276106 0247_ $$2pmid$$apmid:37202505
000276106 0247_ $$2ISSN$$a1350-9047
000276106 0247_ $$2ISSN$$a1476-5403
000276106 0247_ $$2altmetric$$aaltmetric:148601085
000276106 037__ $$aDKFZ-2023-01006
000276106 041__ $$aEnglish
000276106 082__ $$a610
000276106 1001_ $$0P:(DE-He78)1f8ddd7e4fcde6a06c1baf67829b13c0$$aMaier, Carina Ramona$$b0$$eFirst author
000276106 245__ $$aUSP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer.
000276106 260__ $$aLondon$$bMacmillan$$c2023
000276106 3367_ $$2DRIVER$$aarticle
000276106 3367_ $$2DataCite$$aOutput Types/Journal article
000276106 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1688377015_27715
000276106 3367_ $$2BibTeX$$aARTICLE
000276106 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000276106 3367_ $$00$$2EndNote$$aJournal Article
000276106 500__ $$a#EA:A410#LA:A410# / 2023 Jul;30(7):1710-1725
000276106 520__ $$aSREBP2 is a master regulator of the mevalonate pathway (MVP), a biosynthetic process that drives the synthesis of dolichol, heme A, ubiquinone and cholesterol and also provides substrates for protein prenylation. Here, we identify SREBP2 as a novel substrate for USP28, a deubiquitinating enzyme that is frequently upregulated in squamous cancers. Our results show that silencing of USP28 reduces expression of MVP enzymes and lowers metabolic flux into this pathway. We also show that USP28 binds to mature SREBP2, leading to its deubiquitination and stabilisation. USP28 depletion rendered cancer cells highly sensitive to MVP inhibition by statins, which was rescued by the addition of geranyl-geranyl pyrophosphate. Analysis of human tissue microarrays revealed elevated expression of USP28, SREBP2 and MVP enzymes in lung squamous cell carcinoma (LSCC) compared to lung adenocarcinoma (LADC). Moreover, CRISPR/Cas-mediated deletion of SREBP2 selectively attenuated tumour growth in a KRas/p53/LKB1 mutant mouse model of lung cancer. Finally, we demonstrate that statins synergise with a dual USP28/25 inhibitor to reduce viability of SCC cells. Our findings suggest that combinatorial targeting of MVP and USP28 could be a therapeutic strategy for the treatment of squamous cell carcinomas.
000276106 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000276106 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000276106 7001_ $$00000-0002-5663-645X$$aHartmann, Oliver$$b1
000276106 7001_ $$00000-0002-7576-1061$$aPrieto-Garcia, Cristian$$b2
000276106 7001_ $$0P:(DE-He78)b7a0487a60da451c67d4b0fef6641ed8$$aAl-Shami, Kamal M$$b3$$udkfz
000276106 7001_ $$0P:(DE-He78)e52c8f6ae826320eaf2fb173e162070d$$aSchlicker, Lisa$$b4$$udkfz
000276106 7001_ $$0P:(DE-He78)38900a0e1ae96a725db546cb7b909adb$$aVogel, Felix C E$$b5$$udkfz
000276106 7001_ $$0P:(DE-He78)98fe26d32f03ff72150a756f0e1d2639$$aHaid, Silke$$b6$$udkfz
000276106 7001_ $$aKlann, Kevin$$b7
000276106 7001_ $$aBuck, Viktoria$$b8
000276106 7001_ $$00000-0003-3832-090X$$aMünch, Christian$$b9
000276106 7001_ $$aSchmitz, Werner$$b10
000276106 7001_ $$00000-0001-7142-1281$$aEinig, Elias$$b11
000276106 7001_ $$00000-0003-1889-3022$$aKrenz, Bastian$$b12
000276106 7001_ $$00000-0002-5338-535X$$aCalzado, Marco A$$b13
000276106 7001_ $$00000-0002-0376-6533$$aEilers, Martin$$b14
000276106 7001_ $$aPopov, Nikita$$b15
000276106 7001_ $$00000-0001-7650-8458$$aRosenfeldt, Mathias T$$b16
000276106 7001_ $$00000-0002-7402-7949$$aDiefenbacher, Markus E$$b17
000276106 7001_ $$0P:(DE-He78)94ae391f53fb9285e1b68f9930615af1$$aSchulze, Almut$$b18$$eLast author$$udkfz
000276106 773__ $$0PERI:(DE-600)1496681-5$$a10.1038/s41418-023-01173-6$$n7$$p1710-1725$$tCell death and differentiation$$v30$$x1350-9047$$y2023
000276106 909CO $$ooai:inrepo02.dkfz.de:276106$$pVDB
000276106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1f8ddd7e4fcde6a06c1baf67829b13c0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000276106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b7a0487a60da451c67d4b0fef6641ed8$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000276106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e52c8f6ae826320eaf2fb173e162070d$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000276106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)38900a0e1ae96a725db546cb7b909adb$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000276106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)98fe26d32f03ff72150a756f0e1d2639$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000276106 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)94ae391f53fb9285e1b68f9930615af1$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000276106 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000276106 9141_ $$y2023
000276106 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-30$$wger
000276106 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-30
000276106 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-30
000276106 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-30
000276106 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELL DEATH DIFFER : 2022$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000276106 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bCELL DEATH DIFFER : 2022$$d2023-10-21
000276106 9202_ $$0I:(DE-He78)A410-20160331$$kA410$$lMetabolismus und Microenvironment$$x0
000276106 9201_ $$0I:(DE-He78)A410-20160331$$kA410$$lMetabolismus und Microenvironment$$x0
000276106 9200_ $$0I:(DE-He78)A410-20160331$$kA410$$lMetabolismus und Microenvironment$$x0
000276106 980__ $$ajournal
000276106 980__ $$aVDB
000276106 980__ $$aI:(DE-He78)A410-20160331
000276106 980__ $$aUNRESTRICTED